'''Mesocarb''' (brand names '''Sidnocarb''', '''Sydnocarb''') is a [[stimulant]] [[drug]] which was developed in the [[USSR]] in the 1970s.<ref>GB Patent 1262830 - NOVEL SYDNONIMINE DERIVATIVE</ref><ref>{{cite journal |author1=Anokhina IP |author2=Zabrodin GD |author3=Svirinovskiĭ IaE |title=[Характеристика центрального действия сиднокарба] |language=Russian |journal=Zh Nevropatol Psikhiatr Im S S Korsakova |volume=74 |issue=4 |pages=594–602 |year=1974 |pmid=4825943 |trans_title=Characteristics of the central action of sidnocarb |issn=1997-7298}}</ref> It has been found to act as a selective [[dopamine reuptake inhibitor]],<ref name="pmid7312716">{{cite journal | vauthors = Erdö SL, Kiss B, Rosdy B | title = Inhibition of dopamine uptake by a new psychostimulant mesocarb (Sydnocarb) | journal = Pol J Pharmacol Pharm | volume = 33 | issue = 2 | pages = 141–7 | year = 1981 | pmid = 7312716 | doi = | url = }}</ref><ref>{{cite journal |doi=10.1111/j.1749-6632.2000.tb05191.x |vauthors=Anderzhanova EA, Afanas'ev II, Kudrin VS, Rayevsky KS |title=Effect of d-amphetamine and sydnocarb on the extracellular level of dopamine, 3,4-dihydroxyphenylacetic acid, and hydroxyl radicals generation in rat striatum |journal=Ann N Y Acad Sci |volume=914 |pages=137–45 |date=September 2000|pmid=11085316 |url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0077-8923&date=2000&volume=914&spage=137}}</ref><ref>{{cite journal |vauthors=Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS |title=Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo |journal=Eur J Pharmacol. |volume=340 |issue=1 |pages=53–8 |date=December 1997|pmid=9527506 |url=http://linkinghub.elsevier.com/retrieve/pii/S0014-2999(97)01407-6 |doi=10.1016/S0014-2999(97)01407-6}}</ref> and is less potent and slower-acting but longer-lasting than [[dextroamphetamine]].<ref>{{cite journal |vauthors=Afanas'ev II, Anderzhanova EA, Kudrin VS, Rayevsky KS |title=Effects of amphetamine and sydnocarb on dopamine release and free radical generation in rat striatum |journal=Pharmacol Biochem Behav. |volume=69 |issue=3–4 |pages=653–8 |year=2001 |pmid=11509228 |url=http://linkinghub.elsevier.com/retrieve/pii/S0091-3057(01)00574-3 |doi=10.1016/S0091-3057(01)00574-3}}</ref>

 
Mesocarb was used for a variety of applications;<ref>{{cite journal  |vauthors=Witkin JM, Savtchenko N, Mashkovsky M, etal |title=Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine |journal=J Pharmacol Exp Ther. |volume=288 |issue=3 |pages=1298–310 |date=1 March 1999|pmid=10027871 |url=http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=10027871 }}</ref> these include counteracting the sedative effects of [[benzodiazepine]] drugs,<ref>{{cite journal |vauthors=Valueva LN, Tozhanova NM |title=[Коррекция мезокарбом побочного действия транквилизаторов бензодиазепинового ряда] |language=Russian |journal=Zh Nevropatol Psikhiatr Im S S Korsakova |volume=82 |issue=8 |pages=92–7 |year=1982 |pmid=6127851 |trans_title=Sidnocarb correction of the adverse effects of benzodiazepine tranquilizers}}</ref> increasing workload capacity and cardiovascular function,<ref>{{cite journal |vauthors=Vinar O, Klein DF, Potter WZ, Gause EM |title=A survey of psychotropic medications not available in the United States |journal=Neuropsychopharmacology |volume=5 |issue=4 |pages=201–17 |date=December 1991|pmid=1804161 }}</ref> treatment of [[ADHD]] and hyperactivity in children,<ref>{{cite journal |author1=Turova NF |author2=Misionzhnik EIu |author3=Ermolina LA |author4=Aziavchik AV |author5=Krasov VA |title=[Экскреция моноаминов, их предшественников и метаболитов при гиперактивном синдроме у детей с интеллектуальной недостаточностью] |language=Russian |journal=Vopr Med Khim. |volume=34 |issue=1 |pages=47–50 |year=1988 |pmid=3369126 |trans_title=Excretion of monoamines, their precursors and metabolites in the hyperactivity syndrome in mentally defective children }}</ref><ref>{{cite journal |author=Krasov VA |title=[Лечение мезокарбом детей младшего школьного возраста с гипердинамическим синдромом] |language=Russian |journal=Zh Nevropatol Psikhiatr Im S S Korsakova |volume=88 |issue=8 |pages=97–101 |year=1988 |pmid=3195293 |trans_title=Sidnocarb treatment of young schoolchildren with the hyperdynamic syndrome }}</ref> as a [[nootropic]],<ref>{{cite journal |author1=Ganiev MM |author2=Kharlamov AN |author3=Raevskiĭ KS |author4=Guseĭnov DIa |title=[Effect of sidnocarb on learning and memory] |language=Russian |journal=Biull Eksp Biol Med |volume=104 |issue=10 |pages=453–4 |date=October 1987|pmid=3676468 |trans_title=Effect of sidnocarb on learning and memory }}</ref> and as a drug to enhance resistance to extremely cold temperatures.<ref>{{cite journal |vauthors=Barer AS, Lakota NG, Ostrovskaia GZ, Shashkov VS |title=[Фармакологическая коррекция холодовых воздействий на человека] |language=Russian |journal=Kosm Biol Aviakosm Med |volume=22 |issue=6 |pages=66–73 |date=Nov–Dec 1988 |pmid=2906380 |trans_title=Pharmacologic correction of the effect of cold on man }}</ref><ref>{{cite journal |vauthors=Levina MN, Badyshtov BA, Gan'shina TS |title=[Thermoprotector properties of a combination of sydnocarb with ladasten] |language=Russian |journal=Eksp Klin Farmakol |volume=69 |issue=1 |pages=71–3 |year=2006 |pmid=16579065 |trans_title=Thermoprotector properties of a combination of sydnocarb with ladasten }}</ref> It is also listed as having [[antidepressant]] and [[anticonvulsant]] properties.
